Dr. Dimitris Panagopoulos took over the position of the Head of the scientific council of the International Research Cloud for Biochemistry & Biotechnology (IRCBB), inaugurating the unification of research protocols between the collaborating organizations. The renowned and award-winning molecular biologist is also the CEO of Green Biotech in Germany and Greece. Green Biotech is one of the 34 official members of the International Research Cloud for Biochemistry & Biotechnology (IRCBB), the association of approved and certified biotechnology companies offering a wide range of innovative services. The entirety of the methods and protocols used follow international scientific standards in accordance with EN ISO / IEC 17025, 15189, 13485, 14001, 37001, are accepted and approved as scientifically valid and effective by EAA, NCBI, EMBO, AASA, AAS, WHO, FDA, EMA, WTO, and IDO.
Dr. Dimitris Panagopoulos was born in 1977 in Greece, where he received his early education. He studied biology at the University of Crete, where he received an honorary scholarship annually. In 2000, he received his academic degree with specification in molecular biology.
Later, he was accepted by the biology department of the University of Athens for his Ph.D. – carried out at the “Alexander Fleming” biomedical sciences research center (under director Dr. George Mosialos). Each year of his studies, he was awarded the Alexander Fleming honorary scholarship. In 2004, he received Ph.D. in molecular biology from the biology department of Athens University.
Meanwhile, he was accepted by the postgraduate MBA of the University of Frankfurt, where he attended in 2002-2003, holding the Wolfgang Goethe scholarship. In 2005, he received a second Ph.D. in genetics and bioinformatics from the biotechnology department of Frankfurt University.
In 2005, Dr. Dimitris Panagopoulos founded a biotechnology company in Germany, Green Biotech, later expanding it to Greece. Green Biotech was awarded the innovation award in biotechnology in 2012/2016/2017 in the EU and 2018/2020 in the United States.
